Cord blood banking preserves blood-forming stem cells from a newborn’s umbilical cord for potential future medical use. Private banking typically costs $1,500 to $3,000 upfront, plus $150 to $300 per year for storage, though some providers offer prepaid multi-year plans. Public donation is free.
Cord blood is an established stem cell source for certain blood cancers and immune disorders, but most families are unlikely to use a privately stored unit. This guide breaks down the costs, the conditions cord blood is proven to treat, and the key differences between public and private banking. Buying a donor cord injection for a joint is a separate decision, covered in our umbilical cord stem cells guide.
What cord blood banking is
After a baby is born, blood remaining in the umbilical cord and placenta contains hematopoietic (blood-forming) stem cells, the same broad cell type used in bone marrow transplants. Collection is done immediately after birth and after the cord is clamped, poses no risk to mother or baby, and takes only a few minutes. That blood can then be frozen and stored, either privately for your own family’s potential future use, or donated to a public bank where it becomes available to any matching patient in need.
Delayed Cord Clamping and Banking
Delayed cord clamping can reduce the volume of blood available for cord blood banking, but clinical guidelines prioritize the newborn’s immediate health. The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion No. 814 recommends delayed umbilical cord clamping for at least 30 to 60 seconds after birth for vigorous term and preterm infants. In term infants, ACOG reports that delayed clamping increases hemoglobin levels at birth and improves iron stores in the first several months of life. For preterm infants, ACOG says delayed clamping is associated with less need for blood transfusion and a lower incidence of necrotizing enterocolitis and intraventricular hemorrhage.
ACOG addresses the trade-off directly in Committee Opinion No. 771. The guidance states that cord blood collection should not compromise obstetric or neonatal care or alter the routine practice of delayed cord clamping, outside the rare exception of medical indications for directed donation.
Research shows that delaying cord clamping lowers the weight and volume of the collected unit. One study observed that the total nucleated cell count was maintained at 30 and 60 seconds, allowing a similar number of units to meet public banking eligibility thresholds. Even so, a smaller or lower-cell-count collection may be rejected by a bank.
Because banking practices vary, resolve two questions in writing before your due date:
- Ask your obstetric provider about their clamping practice.
- Ask the cord blood bank how it handles a unit that falls below its processing minimum, and whether the bank refunds your collection fee if the sample is rejected.
For related reading, see our guide on umbilical cord stem cells or how to vet a clinic.
Private banking: what it costs
Private cord blood banking typically involves an upfront collection and processing fee of $1,500 to $3,000, plus ongoing annual storage of roughly $150 to $300. Some banks instead offer prepaid multi-year or lifetime storage plans, commonly in the $3,000 to $6,000 range, which can work out cheaper than paying annual fees over many years. Exact pricing varies significantly by bank, so compare the total cost over the number of years you expect to store the unit, not just the headline upfront fee.
Public banking: free, but not reserved for your family
Public cord blood banks accept donations at no cost to the donor family and make the unit available, through registries like Be The Match, to any matching patient who needs a transplant, similar to how a public blood bank works. The tradeoff is access: once donated, that unit is no longer reserved for your family, though donating does not reduce your family’s ability to access other public units later if a need arises. Not every hospital participates in public donation programs, so availability depends on where you deliver.
What cord blood is actually proven to treat
Cord blood is an FDA-recognized source of hematopoietic stem cells used in transplants for certain leukemias, lymphomas, and a range of inherited blood, metabolic, and immune disorders, the same broad category of use as a bone marrow transplant. This is genuinely established medicine, not an experimental claim.
What cord blood is not currently proven to treat is a longer list of conditions sometimes mentioned in banking marketing, such as cerebral palsy or autism. Research into these uses is ongoing in clinical trials, but as of 2026 they remain investigational, not established treatments you should bank in expectation of using.
Is it worth it for your family?
The honest answer depends on your family’s specific risk factors, not a universal yes or no. Banking has clearer value if your family has a history of a condition treatable by a hematopoietic stem cell transplant, or if you have another child who might need a matched donor, a sibling’s cord blood is more likely to be a usable match than a stranger’s. For an average-risk family with no such history, the probability of ever using a privately stored unit is low, which is a documented reason several professional pediatric and obstetric groups have recommended public donation over private banking as the better default for most families.
That said, “low probability” is not “zero,” and some families weigh the cost as a form of insurance regardless of the odds, especially given ongoing research into new potential uses. This is a values-and-budget decision as much as a medical one.
Public vs. private, side by side
| Private banking | Public donation | |
|---|---|---|
| Cost to your family | $1,500–$3,000 upfront + $150–$300/yr (or prepaid plan) | Free |
| Reserved for your family | Yes | No, available to any matching patient |
| Insurance coverage | Not covered (unless a documented existing medical need applies to FSA/HSA) | N/A, no cost to you |
| Availability | Any participating hospital, with advance enrollment | Only at hospitals that partner with a public bank |
The bottom line
Cord blood banking stores a real, medically useful source of stem cells, but it is not proof against every future illness a marketing page might imply. Private banking runs $1,500 to $6,000 depending on the plan, with an ongoing annual fee if you don’t prepay, while public donation is free but not reserved for your family. Cord blood’s proven use is concentrated in blood cancers and certain inherited disorders; weigh your family’s actual risk factors, not speculative future uses, before deciding which path, private, public, or neither, is worth it for you.
Frequently asked questions
Is cord blood banking worth it?
It depends on your family's risk factors and budget. Cord blood is an established treatment for certain blood cancers and immune disorders, so banking has real value if your family has a history of those conditions or a sibling who might need a matched donor. For an average-risk family, the odds of ever using a privately banked unit are low, which is why many pediatric and OB professional groups recommend public donation over private banking for most families.
Is cord blood banking covered by insurance?
No. Private cord blood banking is considered an elective, optional service and is not covered by health insurance. Public cord blood donation is free to the donor family, since the public bank covers collection and processing costs in exchange for making the unit available to any patient who needs it.
Is cord blood banking tax deductible or FSA/HSA eligible?
It can qualify as an eligible medical expense under an FSA or HSA if a physician documents a specific existing medical need in your family, such as a sibling with a condition treatable by a stem cell transplant. Without that documented medical need, private cord blood banking is generally treated as an elective expense and does not qualify. Check with your plan administrator and a tax professional before assuming it qualifies.
How long does a banked cord blood unit last?
Cord blood units frozen using standard cryopreservation are viable for storage periods well beyond 20 years, based on published data on stored units, and public cord blood banks have successfully used units stored for over two decades in transplants. No firm expiration date has been established.
Why is cord blood banking considered controversial?
The main controversy is about value for money rather than safety: critics, including some professional medical bodies, argue that private banking oversells the odds an average family will ever use their stored unit, given cord blood's proven uses are concentrated in specific inherited and blood-cancer conditions. Private banking companies counter that new investigational uses are being studied, which could expand future value. Both points are true; the decision comes down to your family's specific risk and budget.
What is cord blood banking actually proven to treat?
Cord blood is an FDA-recognized source of blood-forming (hematopoietic) stem cells used in transplants for certain leukemias, lymphomas, and inherited blood, metabolic, and immune disorders. Uses beyond hematopoietic transplant, such as for cerebral palsy or autism, remain investigational and are being studied in clinical trials, not established treatments.
Does cord blood banking make sense once my child turns 18?
Yes, the stored unit stays viable well past 18, so turning 18 is not an expiration point. Cord blood units frozen using standard cryopreservation are viable for storage periods well beyond 20 years, the same figure cited above, so a unit does not stop being useful at any set age. The decision at that stage is a budget one, not a biological one: keep paying the annual storage fee, switch to a prepaid long-term plan if the bank offers one, or let the unit go and rely on public banks if a need arises later. Some banks also transfer account control to the now-adult child at 18, so check your specific bank's policy on ownership and continued fees.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.